PL315530A1 - Derivatives of 5-nitroimidazole in the form of microgranules - Google Patents
Derivatives of 5-nitroimidazole in the form of microgranulesInfo
- Publication number
- PL315530A1 PL315530A1 PL95315530A PL31553095A PL315530A1 PL 315530 A1 PL315530 A1 PL 315530A1 PL 95315530 A PL95315530 A PL 95315530A PL 31553095 A PL31553095 A PL 31553095A PL 315530 A1 PL315530 A1 PL 315530A1
- Authority
- PL
- Poland
- Prior art keywords
- microgranules
- derivatives
- medicinal
- nitroimidazole
- hand
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9400394A FR2715067B1 (en) | 1994-01-14 | 1994-01-14 | New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract. |
PCT/FR1995/000039 WO1995019168A1 (en) | 1994-01-14 | 1995-01-12 | Microgranules of 5-nitro imidazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
PL315530A1 true PL315530A1 (en) | 1996-11-12 |
PL178424B1 PL178424B1 (en) | 2000-04-28 |
Family
ID=9459066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL95315530A PL178424B1 (en) | 1994-01-14 | 1995-01-12 | Derivatives of 5-nitroimidazole in the form of microgranules |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPH09507499A (en) |
KR (1) | KR100320140B1 (en) |
CN (1) | CN1088357C (en) |
AT (1) | ATE187068T1 (en) |
AU (1) | AU705570B2 (en) |
BR (1) | BR9506507A (en) |
CZ (1) | CZ286080B6 (en) |
DE (1) | DE69513632T2 (en) |
DK (1) | DK0739201T3 (en) |
ES (1) | ES2139883T3 (en) |
MA (1) | MA23429A1 (en) |
MX (1) | MX9602772A (en) |
NZ (1) | NZ279238A (en) |
OA (1) | OA10583A (en) |
PL (1) | PL178424B1 (en) |
PT (1) | PT739201E (en) |
RU (1) | RU2152212C1 (en) |
SK (1) | SK282066B6 (en) |
UA (1) | UA28031C2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4331930B2 (en) * | 2001-10-17 | 2009-09-16 | 武田薬品工業株式会社 | High content granules of acid labile drugs |
US10335390B2 (en) | 2014-09-05 | 2019-07-02 | Symbiomix Therapeutics, Llc | Secnidazole for use in the treatment of bacterial vaginosis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256684A (en) * | 1985-06-13 | 1993-10-26 | The Procter & Gamble Company | Methods and compositions for the treatment of gastrointestinal disorders |
DE3822095A1 (en) * | 1988-06-30 | 1990-01-04 | Klinge Co Chem Pharm Fab | NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF |
EP0528971B1 (en) * | 1990-05-14 | 1999-09-01 | JERNBERG, Gary R. | Surgical implant and method incorporating chemotherapeutic agents |
-
1995
- 1995-01-12 PT PT95907683T patent/PT739201E/en unknown
- 1995-01-12 RU RU96117257/14A patent/RU2152212C1/en not_active IP Right Cessation
- 1995-01-12 AT AT95907683T patent/ATE187068T1/en not_active IP Right Cessation
- 1995-01-12 UA UA96083232A patent/UA28031C2/en unknown
- 1995-01-12 NZ NZ279238A patent/NZ279238A/en unknown
- 1995-01-12 AU AU15803/95A patent/AU705570B2/en not_active Ceased
- 1995-01-12 ES ES95907683T patent/ES2139883T3/en not_active Expired - Lifetime
- 1995-01-12 MX MX9602772A patent/MX9602772A/en not_active IP Right Cessation
- 1995-01-12 PL PL95315530A patent/PL178424B1/en not_active IP Right Cessation
- 1995-01-12 SK SK914-96A patent/SK282066B6/en unknown
- 1995-01-12 CN CN95191222A patent/CN1088357C/en not_active Expired - Fee Related
- 1995-01-12 JP JP7518878A patent/JPH09507499A/en active Pending
- 1995-01-12 KR KR1019960703797A patent/KR100320140B1/en not_active IP Right Cessation
- 1995-01-12 BR BR9506507A patent/BR9506507A/en not_active IP Right Cessation
- 1995-01-12 CZ CZ19962055A patent/CZ286080B6/en not_active IP Right Cessation
- 1995-01-12 DK DK95907683T patent/DK0739201T3/en active
- 1995-01-12 DE DE69513632T patent/DE69513632T2/en not_active Expired - Fee Related
- 1995-01-13 MA MA23756A patent/MA23429A1/en unknown
-
1996
- 1996-07-12 OA OA60863A patent/OA10583A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU705570B2 (en) | 1999-05-27 |
CN1138826A (en) | 1996-12-25 |
CZ286080B6 (en) | 2000-01-12 |
NZ279238A (en) | 1998-03-25 |
MX9602772A (en) | 1997-05-31 |
DE69513632T2 (en) | 2000-04-06 |
SK91496A3 (en) | 1996-12-04 |
SK282066B6 (en) | 2001-10-08 |
BR9506507A (en) | 1997-09-09 |
CN1088357C (en) | 2002-07-31 |
ES2139883T3 (en) | 2000-02-16 |
RU2152212C1 (en) | 2000-07-10 |
PL178424B1 (en) | 2000-04-28 |
OA10583A (en) | 2002-07-10 |
UA28031C2 (en) | 2000-10-16 |
DK0739201T3 (en) | 2000-05-01 |
KR100320140B1 (en) | 2002-07-02 |
ATE187068T1 (en) | 1999-12-15 |
DE69513632D1 (en) | 2000-01-05 |
AU1580395A (en) | 1995-08-01 |
PT739201E (en) | 2000-05-31 |
MA23429A1 (en) | 1995-10-01 |
CZ205596A3 (en) | 1996-10-16 |
JPH09507499A (en) | 1997-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9707334A (en) | Pharmaceutical composition containing selected lanthanum carbonate hydrates. | |
MY109880A (en) | Substituted biphenylpyridones | |
ZA971324B (en) | Powdered medication inhaler. | |
ZA973022B (en) | New pharmaceutical composition with anaesthetic effect. | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
AU763094C (en) | Benzimidazoles, production thereof and use thereof as medicaments | |
AU1392900A (en) | 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses | |
IL138702A0 (en) | Substituted indolinones, the production thereof and their use as medicaments | |
AU8918998A (en) | Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection | |
IL126714A (en) | Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation | |
NZ330360A (en) | 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents | |
USD404097S (en) | Practice bat | |
CZ2000522A3 (en) | Pharmaceutical preparation based on piperidinalkanol antihistaminic and use thereof | |
WO2003045429A3 (en) | Anti-t cell immunotoxin fusion protein and its therapeutic use | |
AU2011501A (en) | Benzimidazoles, production thereof and the use thereof as antithrombotic | |
PL315530A1 (en) | Derivatives of 5-nitroimidazole in the form of microgranules | |
EP1226836A4 (en) | Suction connector and suction catheter using the connector | |
NZ501832A (en) | Angiotensin-peptide carrier conjugates for treating diseases associated with the renin-angiotensin system | |
USD479129S1 (en) | Connector for bottle co-pack | |
ZA986273B (en) | Purine derivatives and the use for medicine thereof. | |
HK1045514A1 (en) | Optically pure camptothecin analogues and composition and use thereof. | |
USD475462S1 (en) | Electrode arrangement for a portable cardiogram recorder | |
USD424127S (en) | Animal puzzle | |
ZA989312B (en) | Novel pharmaceutically active compounds, their preparation and use. | |
HK1052176A1 (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20050112 |